Study Summary
This trial is testing whether adding chemotherapy before and after surgery is better than just after surgery for treating gallbladder cancer.
- Stage IIB Gallbladder Cancer
- Stage III Gallbladder Cancer
- Stage IIIB Gallbladder Cancer
- Stage IIIA Gallbladder Cancer
- Stage II Gallbladder Cancer
- Stage IIA Gallbladder Cancer
Treatment Effectiveness
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Up to 5 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Arm I (surgery, adjuvant therapy)
1 of 2
Arm II (neoadjuvant therapy, surgery, adjuvant therapy)
1 of 2
Active Control
Experimental Treatment
186 Total Participants · 2 Treatment Groups
Primary Treatment: Lymphadenectomy · No Placebo Group · Phase 2 & 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the standard procedure for Lymphadenectomy?
"Lymphadenectomy, which is the surgical removal of lymph nodes, is most often used to treat neoplasm metastasis. However, it is also a viable option for treating small cell lung cancer (sclc), urinary bladder, and advanced testicular cancer." - Anonymous Online Contributor
Are there other scientific papers which explore Lymphadenectomy in detail?
"Out of the 1064 active clinical trials studying Lymphadenectomy, 361 are in Phase 3. The majority of these Lymphadenectomy trials are based in Shanghai; however, there are 53176 total locations running trials for Lymphadenectomy." - Anonymous Online Contributor